Computational Molecular Biology 2016, Vol.6, No.2, 1-9
9
Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., and van Duijn C.M., 1997, Effects of
age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta
analysis consortium, JAMA, 278: 1349–1356.
Hardy J., and Crook R., 2001, Presenilin mutations line up along transmembrane alpha-helices, Neurosci Lett, 306: 203-205.
Herz J., and Chen Y., 2006, Reelin, lipoprotein receptors and synaptic plasticity, Nat Rev Neurosci, 7: 850–859.
Jonsson T., Atwal J.K., Steinberg S., Snaedal J., Jonsson P.V., Bjornsson S., Stefansson H., Sulem P., Gudbjartsson D., Maloney J., Hoyte K., Gustafson A., Liu
Y., Lu Y., Bhangale T., Graham R.R., Huttenlocher J., Bjornsdottir G., Andreassen O.A., Jonsson E.G., Palotie A., Behrens T.W., Magnusson O.T., Kong A.,
Thorsteinsdottir U., Watts R.J., and Stefansson K., 2012, A mutation in APP protects against Alzheimer's disease and age-related cognitive decline, Nature
488: 96-99.
Kauwe J.S., Jacquart S., Chakraverty S., Wang J., Mayo K., Fagan A.M., Holtzman D.M., Morris J.C., and Goate A.M., 2007, Extreme cerebrospinal fluid
amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation, Annals of neurology, 61: 446-453.
Kwok J.B., Li Q.X., Hallupp M., Whyte S., Ames D., Beyreuther K., Masters C.L., and Schofield P.R., 2000, Novel Leu723Pro amyloid precursor protein
mutation increases amyloid beta42(43) peptide levels and induces apoptosis, Annals of neurology, 47: 249-253.
Liu C.C., Kanekiyo T., Xu H., and Bu G., 2013, Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy, Nat Rev Neurol, 9: 106–118.
Laws S.M., Hone E., Gandy S., and Martins R.N., 2003, Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles
for APOE promoter polymorphisms and alterations in APOE transcription, J Neurochem, 84: 1215–1236.
Mahley R.W., 1988, Apolipoprotein E: cholesterol transport protein with expanding role in cell biology, Science, 240: 622–630.
Nilsberth C., Westlind-Danielsson A., Eckman C.B., Condron M.M., Axelman K., Forsell C., Stenh C., Luthman J., Teplow D.B., Younkin S.G., Naslund J., and
Lannfelt L., 2001, The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation, Nat Neurosci, 4: 887-893.
Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M.,
Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., and Younkin S., 1996, Secreted amyloid beta-protein similar to that in
the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease, Nat Med
2: 864-870.
Suzuki N., Cheung T.T., Cai X.D., Odaka A., Otvos L., Eckman C., Golde T.E., and Younkin S.G., 1994, An increased percentage of long amyloid beta protein
secreted by familial amyloid beta protein precursor (beta APP717) mutants, Science, 264: 1336-1340.
Tomiyama T., Nagata T., Shimada H., Teraoka R., Fukushima A., Kanemitsu H., Takuma H., Kuwano R., Imagawa M., Ataka S., Wada Y., Yoshioka E.,
Nishizaki T., Watanabe Y., and Mori H., 2008, A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia, Annals of neurology, 63:
377-387.
Theuns J., and Van Broeckhoven C., 2000, Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility, Hum Mol Genet, 9:
2383–2394.
Taddei K., Clarnette R., Gandy S.E., Martins R.N., 1997, Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease, Neurosci Lett, 223: 29–32.
Zheng H., and Koo E.H., 2011, Biology and pathophysiology of the amyloid precursor protein, Mol Neurodegener, 6: 27.
Zhou L., Brouwers N., Benilova I., Vandersteen A., Mercken M., Van Laere K., Van Damme P., Demedts D., Van Leuven F., Sleegers K., Broersen K., Van
Broeckhoven C., Vandenberghe R., and De Strooper B., 2011, Amyloid precursor protein mutation E682K at the alternative beta-secretase cleavage
beta'-site increases Abeta generation, EMBO molecular medicine, 3: 291-302.
Zhong N., and Weisgraber K.H., 2009, Understanding the association of apolipoprotein E4 with Alzheimer disease: clues from its structure, J Biol Chem, 284:
6027–6031.
